ask="N/A"
ask_size="N/A"
average_daily_volume="388144"
bid="1.00"
bid_size="100"
book_value="14.23"
change="-1.05"
change_from_200_day_moving_average="-10.53"
change_from_50_day_moving_average="-5.60"
change_from_52_week_high="-22.07"
change_From_52_week_low="4.57"
change_in_percent="-2.63%"
close="38.91"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-97.47M"
eps_estimate_current_year="-4.38"
eps_estimate_next_quarter="-1.15"
eps_estimate_next_year="-3.84"
ex_dividend_date="N/A"
float_shares="24661000"
high="40.08"
high_52_weeks="60.98"
last_trade_date="3/17/2017"
last_trade_price="38.91"
last_trade_size="100"
last_trade_time="4:00pm"
low="38.72"
low_52_weeks="34.34"
market_capitalization="1.07B"
moving_average_200_day="49.44"
moving_average_50_day="44.51"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="48.50"
open="39.50"
pe_ratio="N/A"
peg_ratio="0.15"
percent_change_from_200_day_moving_average="-21.29%"
percent_change_from_50_day_moving_average="-12.58%"
percent_change_from_52_week_high="-36.19%"
percent_change_from_52_week_low="+13.31%"
previous_close="39.96"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.81"
price_per_sales="35.82"
revenue="30.69M"
shares_outstanding="27509000"
short_ratio="9.22"
stock_exchange="NMS"
symbol="FPRX"
volume="910161"
weeks_range_52="34.34 - 60.98"
